CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
- 4 Grant or award Director acquired 28,721 shares (grant or award)
- 4 Grant or award Director acquired 25,371 shares (grant or award)
- 4 Grant or award Director acquired 30,157 shares (grant or award)
- 4 Grant or award Director acquired 38,294 shares (grant or award)
- 4 Grant or award Director acquired 26,329 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 11,000 shares at $1.81 ($19,912)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 4 Grant or award Chief Executive Officer acquired 180,702 shares (grant or award)
- 4 Grant or award Chief of R&D acquired 26,316 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 26,316 shares (grant or award)
- 8-K Event Shareholder vote results
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
Page 4 of 21 · 420 filings